PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update

• Recruitment Progressing as Planned with Over 3 00 Patients Enrolled into Phase 3 SHIELD I Trial of D-PLEX 100 in Abdominal Surgery • FDA Agreed that a Single Pivotal Phase 3 Study is Sufficient for Potential Approval of D-PLEX 100 for the Prevention of Surgical Site Infections in